БЛОГ

Archive for the ‘genetics’ category

Oct 1, 2024

New Tool Quantifies Cancer’s Ability to Shape-Shift

Posted by in categories: biotech/medical, genetics, neuroscience

A powerful new analytical tool offers a closer look at how tumor cells “shape-shift” to become more aggressive and untreatable, as shown in a study from researchers at Weill Cornell Medicine and the New York Genome Center.

A tumor cell shape-shifts by changing its cell type or state, thus altering its basic pattern of activity and perhaps even its appearance. This changeability or “plasticity” is a characteristic of cancer that leads to diverse tumor-cell populations and ultimately the emergence of cell types enabling treatment resistance and metastatic spread.

The new tool, described Sept. 24 in a paper in Nature Genetics, can be used to quantify this plasticity in samples of tumor cells. The researchers demonstrated it with analyses of tumor samples from animal models and human patients, identifying, for example, a key transitional cell state in glioblastoma, the most common form of brain cancer.

Oct 1, 2024

New therapy for glioma receives FDA approval

Posted by in categories: biotech/medical, genetics, neuroscience

The FDA has approved a new targeted drug specifically for brain tumors called low-grade gliomas. The drug, vorasidenib, was shown in clinical trials to delay progression of low-grade gliomas that had mutations in the IDH1 or IDH2 genes.

“Although there have been other targeted therapies for the treatment of brain tumors with the IDH mutation, [this one] has been one of the most successful in survival prolongation of brain tumor patients,” said Darell Bigner, MD, PhD, the E. L. and Lucille F. Jones Cancer Distinguished Research Professor and founding director of the Preston Robert Tisch Brain Tumor Center at Duke.

In clinical trials, progression-free survival was estimated to be 27.7 months for people in the vorasidenib group versus 11.1 months for those in the placebo group.

Sep 30, 2024

Spinning artificial spider silk into next-generation medical materials

Posted by in categories: bioengineering, biotech/medical, education, genetics

Spider silk is one of the strongest materials on Earth, technically stronger than steel for a material of its size. However, it’s tough to obtain—spiders are too territorial (and cannibalistic) to breed them like silkworms, leading scientists to turn to artificial options.

Teaching microbes to produce the through is one such option, but this has proved challenging because the proteins tend to stick together, reducing the silk’s yield. So, Bingbing Gao and colleagues wanted to modify the natural protein sequence to design an easily spinnable, yet still stable, spider silk using microbes.

The team first used these microbes to produce the silk proteins, adding extra peptides as well. The new peptides, following a pattern found in the protein sequence of amyloid polypeptides, helped the artificial silk proteins form an orderly structure when folded and prevented them from sticking together in solution, increasing their yield.

Sep 29, 2024

CRISPR CREME: An AI Treat to Enable Virtual Genomic Experiments

Posted by in categories: biotech/medical, genetics, information science, robotics/AI

Koo and his team tested CREME on another AI-powered DNN genome analysis tool called Enformer. They wanted to know how Enformer’s algorithm makes predictions about the genome. Koo says questions like that are central to his work.

“We have these big, powerful models,” Koo said. “They’re quite compelling at taking DNA sequences and predicting gene expression. But we don’t really have any good ways of trying to understand what these models are learning. Presumably, they’re making accurate predictions because they’ve learned a lot of the rules about gene regulation, but we don’t actually know what their predictions are based off of.”

With CREME, Koo’s team uncovered a series of genetic rules that Enformer learned while analyzing the genome. That insight may one day prove invaluable for drug discovery. The investigators stated, “CREME provides a powerful toolkit for translating the predictions of genomic DNNs into mechanistic insights of gene regulation … Applying CREME to Enformer, a state-of-the-art DNN, we identify cis-regulatory elements that enhance or silence gene expression and characterize their complex interactions.” Koo added, “Understanding the rules of gene regulation gives you more options for tuning gene expression levels in precise and predictable ways.”

Sep 28, 2024

Gut Microbiome and Aspirin May Reverse Hormonal Issues

Posted by in categories: biotech/medical, genetics, neuroscience

Summary: Researchers found that mutations in the Sox3 gene cause hypopituitarism, a condition where the pituitary gland produces insufficient hormones, leading to growth issues and infertility. In a study on mice, they discovered that Sox3 mutations affect brain cells called NG2 glia, which are essential for hormone production.

Treating the mice with aspirin or altering their gut microbiome restored NG2 glia levels and reversed hypopituitarism. These findings suggest that both aspirin and gut bacteria could be explored as potential treatments for people with Sox3 mutations or other hormone-related disorders.

Sep 28, 2024

Genetically engineered bacteria solve computational problems

Posted by in categories: genetics, physics, robotics/AI

Researchers have developed a groundbreaking system that uses bacteria to mimic the problem-solving capabilities of artificial neural networks.


Cell-based biocomputing is a novel technique that uses cellular processes to perform computations. Such micron-scale biocomputers could overcome many of the energy, cost and technological limitations of conventional microprocessor-based computers, but the technology is still very much in its infancy. One of the key challenges is the creation of cell-based systems that can solve complex computational problems.

Now a research team from the Saha Institute of Nuclear Physics in India has used genetically modified bacteria to create a cell-based biocomputer with problem-solving capabilities. The researchers created 14 engineered bacterial cells, each of which functioned as a modular and configurable system. They demonstrated that by mixing and matching appropriate modules, the resulting multicellular system could solve nine yes/no computational decision problems and one optimization problem.

Continue reading “Genetically engineered bacteria solve computational problems” »

Sep 27, 2024

The Soundtrack of Science

Posted by in categories: genetics, science

Meet Barbara Di Ventura, an engineer turned synthetic biologist at the University of Freiburg, who explores protein dynamics across cell types. Outside of the laboratory, she moonlights as a musician. Di Ventura harmonizes her passion for art and science in musical abstracts, using a guitar to riff about her latest research, transforming scientific communication into a lively experience.

What inspired you to start creating musical abstracts?

I was inspired by Uri Alon, a systems biologist at the Weizmann Institute of Science, who played the guitar and sang songs about his group’s projects in an entertaining way. Then in 2021, we published a paper on a novel optogenetic tool for controlling gene expression in bacteria, and I had this vision to write a song about it.1 We’re constantly asked to describe our work in new ways despite the numerous figures we produce. To me, writing song lyrics is easier than new text. The song “American Pie” came to mind, and it sounded cool with “Bye-bye, L-arabinose drive,” where L-arabinose is the normal inducer of this system.

Sep 26, 2024

Scientists discover ‘pause button’ in human development

Posted by in categories: biotech/medical, genetics

In some mammals, the timing of the normally continuous embryonic development can be altered to improve the chances of survival for both the embryo and the mother. This mechanism to temporarily slow development, called embryonic diapause, often happens at the blastocyst stage, just before the embryo implants in the uterus.

During diapause, the embryo remains free-floating and pregnancy is extended. This can be maintained for weeks or months before development is resumed, when conditions are favorable. Although not all mammals use this reproductive strategy, the ability to pause development can be triggered experimentally. Whether human cells can respond to diapause triggers remained an open question.

Now, a study by the labs of Aydan Bulut-Karslıoğlu at the Max Planck Institute for Molecular Genetics in Berlin and Nicolas Rivron at the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna, has identified that the that control embryonic diapause also seem to be actionable in human cells.

Sep 26, 2024

Researchers make breakthrough with genetically engineered wood that could transform the construction industry: ‘One major step for us’

Posted by in categories: genetics, innovation

“We are excited to explore the other trees by applying similar technologies.” first appeared on The Cool Down.

Sep 26, 2024

Cancer breakthrough finally maps how deadly tumors spread through the body

Posted by in categories: biotech/medical, genetics

NEW YORK — In a groundbreaking development, scientists have created a revolutionary method to track the spread of cancer throughout the body, potentially paving the way for more effective treatments against this devastating disease. The new technology, developed by researchers at Cold Spring Harbor Laboratory and Weill Cornell Medicine in New York, uses genetic “barcodes” to monitor the movement of individual cancer cells, providing unprecedented insights into the process of metastasis.

Page 1 of 49812345678Last